Tuttle RL - Search Results

1

Constitutively active Akt1 expression in mouse pancreas requires S6 kinase 1 for insulinoma formation.

Alliouachene S, Tuttle RL, Boumard S, Lapointe T, Berissi S, Germain S, Jaubert F, Tosh D, Birnbaum MJ, Pende M. Alliouachene S, et al. Among authors: tuttle rl. J Clin Invest. 2008 Nov;118(11):3629-38. doi: 10.1172/JCI35237. Epub 2008 Oct 9. J Clin Invest. 2008. PMID: 18846252 Free PMC article.

2

Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha.

Tuttle RL, Gill NS, Pugh W, Lee JP, Koeberlein B, Furth EE, Polonsky KS, Naji A, Birnbaum MJ. Tuttle RL, et al. Nat Med. 2001 Oct;7(10):1133-7. doi: 10.1038/nm1001-1133. Nat Med. 2001. PMID: 11590437

3

Signaling pathways mediating insulin-stimulated glucose transport.

Summers SA, Yin VP, Whiteman EL, Garza LA, Cho H, Tuttle RL, Birnbaum MJ. Summers SA, et al. Among authors: tuttle rl. Ann N Y Acad Sci. 1999 Nov 18;892:169-86. doi: 10.1111/j.1749-6632.1999.tb07795.x. Ann N Y Acad Sci. 1999. PMID: 10842662 Review.

4

Human LATS1 is a mitotic exit network kinase.

Bothos J, Tuttle RL, Ottey M, Luca FC, Halazonetis TD. Bothos J, et al. Among authors: tuttle rl. Cancer Res. 2005 Aug 1;65(15):6568-75. doi: 10.1158/0008-5472.CAN-05-0862. Cancer Res. 2005. PMID: 16061636

5

Defective in mitotic arrest 1/ring finger 8 is a checkpoint protein that antagonizes the human mitotic exit network.

Tuttle RL, Bothos J, Summers MK, Luca FC, Halazonetis TD. Tuttle RL, et al. Mol Cancer Res. 2007 Dec;5(12):1304-11. doi: 10.1158/1541-7786.MCR-07-0388. Mol Cancer Res. 2007. PMID: 18171988

6

Use of CO2/O2 anesthesia in the collection of samples for serum corticosterone analysis from Fischer 344 rats.

Fomby LM, Wheat TM, Hatter DE, Tuttle RL, Black CA. Fomby LM, et al. Among authors: tuttle rl. Contemp Top Lab Anim Sci. 2004 Mar;43(2):8-12. Contemp Top Lab Anim Sci. 2004. PMID: 15053500

7

Phase I clinical and pharmacology study of 502U83 given as a 24-h continuous intravenous infusion.

Schilsky RL, Ratain MJ, Janisch L, Vogelzang NJ, Lucas VS, Ravitch J, Hohneker JA, Clendeninn NJ, Tuttle RL. Schilsky RL, et al. Among authors: tuttle rl. Cancer Chemother Pharmacol. 1993;31(4):283-8. doi: 10.1007/BF00685672. Cancer Chemother Pharmacol. 1993. PMID: 8422691 Clinical Trial.

8

Splenectomy vs. alpha interferon: a randomized study in patients with previously untreated hairy cell leukemia.

Smalley RV, Connors J, Tuttle RL, Anderson S, Robinson W, Whisnant JK. Smalley RV, et al. Among authors: tuttle rl. Am J Hematol. 1992 Sep;41(1):13-8. doi: 10.1002/ajh.2830410104. Am J Hematol. 1992. PMID: 1503094 Clinical Trial.

9

A phase II study of crisnatol mesylate in patients with ovarian carcinoma.

Smalley RV, Goldstein D, Bulkowski D, Hannon C, Buchler D, Knudsen C, Tuttle RL. Smalley RV, et al. Among authors: tuttle rl. Invest New Drugs. 1992 Jul;10(2):107-12. doi: 10.1007/BF00873127. Invest New Drugs. 1992. PMID: 1500264 Clinical Trial.

10

A randomized comparison of two doses of human lymphoblastoid interferon-alpha in hairy cell leukemia. Wellcome HCL Study Group.

Smalley RV, Anderson SA, Tuttle RL, Connors J, Thurmond LM, Huang A, Castle K, Magers C, Whisnant JK. Smalley RV, et al. Among authors: tuttle rl. Blood. 1991 Dec 15;78(12):3133-41. Blood. 1991. PMID: 1742480 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters